MP497OUTCOMES OF PATIENTS WITH SYSTEMIC AMYLOIDOSIS UNDERGOING PERITONEAL DIALYSIS
نویسندگان
چکیده
منابع مشابه
Presentation and outcome of patients with systemic amyloidosis undergoing dialysis.
BACKGROUND AND OBJECTIVES Light chain (AL) and secondary (AA) amyloidosis usually present as a systemic disease frequently involving the kidney and leading to ESRD. Data regarding patients with AA or AL amyloidosis undergoing dialysis remain scarce. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS We retrospectively studied patients with AA or AL amyloidosis who started dialysis in five French c...
متن کاملPeritoneal amyloidosis with myopathy in primary systemic (AL) amyloidosis.
To cite: Al-Adhami A, Steiner K, Ellis S. BMJ Case Rep Published online: [please include Day Month Year] doi:10.1136/bcr-2016216548 DESCRIPTION We present an unusual case of primary systemic amyloidosis presenting with myopathy and peritoneal amyloid deposition. Peritoneal amyloid is a rare disease with few published cases. An 85-year-old man was referred to rheumatology with walking difficulti...
متن کاملImpact of Environmental Particulate Matter and Peritoneal Dialysis-related Infection in Patients Undergoing Peritoneal Dialysis
In patients undergoing peritoneal dialysis (PD), PD-related infection is a major cause of PD failure and hospital admission. Good air quality is required when dialysate exchange or exit site wound care is performed. To our knowledge, investigation of air pollution as a factor for PD-related infection in patients undergoing dialysis is limited. This study aimed to assess the effect of environmen...
متن کاملClinical outcomes of systemic lupus erythematosus patients undergoing continuous ambulatory peritoneal dialysis.
OBJECTIVES The purpose of this study was to evaluate the outcome of systemic lupus erythematosus (SLE) patients on continuous ambulatory peritoneal dialysis (CAPD). METHODS Eighteen SLE patients who had been undergoing CAPD for at least 3 months in our unit were compared with 36 other age- and gender-matched non-diabetic CAPD patients with an underlying primary chronic glomerulonephritis (CGn...
متن کاملPharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis.
The pharmacokinetics of ceftizoxime were studied in 12 patients on continuous ambulatory peritoneal dialysis. After a 3-g intravenous dose, the steady-state volume of distribution was 0.23 +/- 0.05 liter kg-1, with an elimination half-life of 9.7 +/- 5.1 h. The peritoneal clearance of ceftizoxime (2.8 +/- 0.7 ml min-1) contributed modestly to the overall serum clearance of the drug (17.1 +/- 7....
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nephrology Dialysis Transplantation
سال: 2016
ISSN: 1460-2385,0931-0509
DOI: 10.1093/ndt/gfw195.13